-
EP3659623
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3659623
| EP3659623 - METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 11.12.2020 Database last updated on 02.11.2024 | |
| Former | The application has been published Status updated on 01.05.2020 | Most recent event Tooltip | 24.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2020/23] | Inventor(s) | 01 /
KOSTIC, Ana c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill Road Tarrytown, NY 10591-6706 / US | 02 /
KELLY, Ludmila c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill Road Tarrytown, NY 10591-6706 / US | 03 /
LUI, Xia c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill Road Tarrytown, NY 10591-6706 / US | 04 /
CLASSON, Brendan J. c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill Road Tarrytown, NY 10591-6706 / US | [2020/23] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2020/23] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19217695.6 | 10.07.2014 | [2020/23] | Priority number, date | US201361844978P | 11.07.2013 Original published format: US 201361844978 P | [2020/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3659623 | Date: | 03.06.2020 | Language: | EN | [2020/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.04.2020 | Classification | IPC: | A61K39/395, C07K16/28, A61K31/56, A61K39/00, A61P1/04, A61P1/06, A61P1/08, A61P1/12, A61P1/14, A61P11/06, A61P17/00, A61P27/02, A61P37/08 | [2020/23] | CPC: |
C07K16/2866 (EP,IL,KR,US);
A61K39/395 (RU);
A61K39/3955 (IL,KR,US);
A61K31/56 (EP,IL,KR,US);
A61K45/06 (IL,KR,US);
A61K9/0019 (IL,US);
A61P1/04 (EP,IL);
A61P1/06 (EP,IL);
A61P1/08 (EP,IL);
A61P1/12 (EP,IL);
A61P1/14 (EP,IL);
A61P11/06 (EP,IL);
A61P17/00 (EP,IL);
A61P27/02 (EP,IL);
A61P37/08 (EP,IL,RU);
A61K2039/505 (EP,IL,KR,US);
A61K2039/54 (EP,IL,KR,US);
A61K2039/545 (EP,IL,KR,US);
A61K2039/577 (EP,IL,KR,US);
C07K2317/21 (EP,IL,KR,US);
C07K2317/565 (IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/02] |
| Former [2020/23] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | VERFAHREN ZUR BEHANDLUNG VON EOSINOPHILER ÖSOPHAGITIS DURCH VERABREICHUNG EINES IL-4R-HEMMERS | [2020/23] | English: | METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR | [2020/23] | French: | PROCÉDÉS DE TRAITEMENT DE L' SOPHAGITE ÉOSINOPHILE PAR L'ADMINISTRATION D'UN INHIBITEUR IL-4R | [2020/23] | Examination procedure | 03.12.2020 | Amendment by applicant (claims and/or description) | 03.12.2020 | Examination requested [2021/02] | 03.12.2020 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP14748342.4 / EP3019191 | Fees paid | Renewal fee | 18.12.2019 | Renewal fee patent year 03 | 18.12.2019 | Renewal fee patent year 04 | 18.12.2019 | Renewal fee patent year 05 | 18.12.2019 | Renewal fee patent year 06 | 22.07.2020 | Renewal fee patent year 07 | 20.07.2021 | Renewal fee patent year 08 | 21.07.2022 | Renewal fee patent year 09 | 20.07.2023 | Renewal fee patent year 10 | 23.07.2024 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2012047954 (REGENERON PHARMA [US], et al); | by applicant | US7186809 | US7605237 | US7608693 | US8092804 | US2012097565 |